ARS Pharmaceuticals, Inc. SPRY Free cash flow margin

Free cash flow margin at other companies

Aquestive Therapeutics, Inc.AQST

-88.2%-2.2pp

Amneal Pharmaceuticals, Inc.AMRX

4.1%-5.8pp

ViatrisVTRS

13.3%+0.9pp

AMP

Amphastar PharmaceuticalsAMPH

20.9%+5.4pp

Neuropace, Inc.NPCE

-10.3%-3.5pp

Eton Pharmaceuticals, Inc.ETON

17.1%—

FAQ

What is ARS Pharmaceuticals, Inc.'s free cash flow margin?

ARS Pharmaceuticals, Inc. (SPRY) reported free cash flow margin of -177.1% in Q1 2026.

How has ARS Pharmaceuticals, Inc.'s free cash flow margin changed year-over-year?

ARS Pharmaceuticals, Inc.'s free cash flow margin decreased by 717.0% year-over-year, from -21.7% to -177.1%.

What is the long-term trend for ARS Pharmaceuticals, Inc.'s free cash flow margin?

Over 3 years (2022 to 2025), ARS Pharmaceuticals, Inc.'s free cash flow margin has grown at a -59.5% compound annual growth rate (CAGR), from -3,060.6% to -203.1%.

What does free cash flow margin mean?

Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.